MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

VIT-D and Tics Movement Disorder

N. Gemawat (Mumbai, India)

Meeting: 2018 International Congress

Abstract Number: 457

Keywords: Behavioral abnormalities, Neurobehavioral disorders, Tics(also see Gilles de la Tourette syndrome): Etiology and Pathogenesis

Session Information

Date: Saturday, October 6, 2018

Session Title: Pediatric Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: Tics is common childhood movement disorder, with classified variants , typically begin at around 4-5 years of age but often present later at about 9 -10 years,10% of all children are affected, considered to be of a mild clinical significance , as it improves by as child grows with various physical and brain metabolism but it do concern as child psycho-social behavior at various interaction with peers. Though exact pathophysiology is not well understood but theories of developmental immaturity in cortico-neurotramitter pathways is hypotheticated.

Background: Vitamin D has shown property of neuronal modulation as a neurosteroids, which activates neurotransmitters with beneficial effect in some of Tics movement disorder as it regulates nerve growth factor. It prompted us to present our work on effect of vit-D in tics movement disorder.

Methods: 34 children with various form of tics disorder , in age group of 9–12 were analysed & studied with interviews, teachers-peers-parents-self perceptions, who presented with various classified different varients, as mild, simple, clonic,tonic and touretts syndrome, tics movement disorder, during school health check program. All children were given therapeutic doses of vit D and re-evaluted after 6 months.

Results: Out of total 34 children were males 22 (64%) and females 12 (34%) who presented with various tics analysed as 13(38%) eye blinking, 9(26%)shoulder struggling, 7(21%)facial grimacing 4(12%) neck stretching and there was one child with tourette syndrome. The present vit-D study group has shown positive impact on generalized improvement in frequency, duration, intensity of tics movements resulting in improved confidence with enhancement of psychosocial acceptance as perceived by self, teachers, peers and family members after 6 months.

Conclusions: The present study has shown beneficial effect of vitamin D in improving in overall intensity and duration of tics occurrence with psychosocial status resulting successful learning with confident socializing. We feel large elaborative studies will help in establishing positive impact of vitamin D in various tics movement disorder. Many researchers have questioned whether the depletion of vitamin D actually causes these disorders or if vitamin D is a symptom of these disorders. The study consisted of a relatively small number of patients, and further studies are needed to confirm the efficacy of vitamin D in various tics disorder fully answer these questions.

References: Ellis CR, Pataki C. “Background: Childhood Habit Behaviors and Stereotypic Movement Disorder”. Medscape. Retrieved October 6, 2013.

To cite this abstract in AMA style:

N. Gemawat. VIT-D and Tics Movement Disorder [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/vit-d-and-tics-movement-disorder-2/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/vit-d-and-tics-movement-disorder-2/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley